Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Literature
1.
Simone Cesaro, Roberta Corró, Anna Pelosin, Piergiorgio Gamba, Nicola Zadra, Fabio Fusaro, et al (2004) Prospective survey on incidence and outcome of Broviac-Hickman-catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 83(3):183-188CrossRefPubMed
2.
Harter C, Ostendorf T, Bach A, Egerer G, Goldschimidt H, Ho AD (2003) Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patient with hematological malignancies. Support Care Cancer 11:790–794CrossRefPubMed
3.
Raaf JH (1994) Administration of chemotherapeutic agents. Support Care Cancer 2:335–346PubMed
4.
Schiffer CA, Anderson KC, Bennet CL, Bernstein S, Elting LS, Goldsmith M, et al (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1519–1538PubMed
Metadata
Title
Peripherally inserted central venous catheter in pediatric hematological patients
Authors
Simone Cesaro
Andrea Pettenazzo
Luisa Meneghini
Publication date
01-11-2004
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2004
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0608-3

Other articles of this Issue 11/2004

Supportive Care in Cancer 11/2004 Go to the issue

Original Article

Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices

Original Article

Ten years’ activity of the first Italian public hospice for terminally ill patients

Original Article

Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey

Original Article

Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer

Original Article

Association between exercise and quality of life in multiple myeloma cancer survivors

Short Communication

A hidden cause of hypokalemic paralysis in a patient with prostate cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits